Discussion on gemcitabine combined with targeted drugs in the treatment of pancreatic cancer

被引：1

作者：

Huang, Jun-Hao ^{[1
]}

Guo, Wei ^{[1
]}

Liu, Zhe ^{[1
,2
]}

机构：

[1] China Med Univ, Hosp 1, Dept Pancreat Biliary Surg, Shenyang 110001, Liaoning, Peoples R China

[2] China Med Univ, Hosp 1, Dept Pancreat Biliary Surg, 155 Nanjing North St, Shenyang 110001, Liaoning, Peoples R China

来源：

WORLD JOURNAL OF GASTROENTEROLOGY | 2023年 / 29卷 / 03期

关键词：

Pancreatic cancer; Chemotherapy; Targeted therapy; Gemcitabine; Drug; Combination; SURVIVAL; THERAPY;

D O I：

10.3748/wjg.v29.i3.579

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Pancreatic cancer is a malignant tumor with poor prognosis. The treatment of pancreatic cancer depends on the tumor stage and type, and includes local treatment (surgery, radiotherapy and ablation intervention) and systemic therapy (chemotherapy, targeted therapy and immunotherapy). We read with great interest the review "Effective combinations of anti-cancer and targeted drugs for pancreatic cancer treatment" published on World J Gastroenterol and intended to share some of our perspectives in pancreatic cancer treatment. This review presents the therapeutic effects of the combination of gemcitabine and targeted drugs, which gives us a deeper insight into the combination treatments for pancreatic cancer.

引用

页码：579 / 581

页数：3

共 50 条

[1] Comparison of Gemcitabine Combined With Targeted Agent Therapy Versus Gemcitabine Monotherapy in the Management of Advanced Pancreatic Cancer
Li, Qin
Yuan, Zhenyan
Yan, Han
Wen, Zhaoyang
Zhang, Ruixue
Cao, Bangwei
CLINICAL THERAPEUTICS, 2014, 36 (07) : 1054 - 1063
[2] A mixed treatment comparison of toxicity of gemcitabine combined with different targeted drugs in the treatment of advanced or metastatic pancreatic cancer
Dorjee, Penpa
Long, Zi-Wen
CANCER BIOLOGY & THERAPY, 2018, 19 (06) : 497 - 506
[3] Combined gemcitabine and radioimmunotherapy for the treatment of pancreatic cancer
Cardillo, TM
Blumenthal, R
Ying, ZL
Gold, DV
INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (03) : 386 - 392
[4] Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study
Javle, M.
Yu, J.
Garrett, C.
Pande, A.
Kuvshinoff, B.
Litwin, A.
Phelan, J., III
Gibbs, J.
Iyer, R.
BRITISH JOURNAL OF CANCER, 2009, 100 (12) : 1842 - 1845
[5] Meta-analysis of gemcitabine plus nab-paclitaxel combined with targeted agents in the treatment of metastatic pancreatic cancer
Li, Zhong-Hui
Ma, Yin-Jie
Jia, Zong-Hang
Weng, Yue-Yan
Zhang, Ping
Zhu, Shi-Jie
Wang, Fang
WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (27) : 9703 - 9713
[6] A randomized controlled trial of gemcitabine plus cisplatin versus gemcitabine alone in the treatment of metastatic pancreatic cancer
Chao, Yee
Wu, Chen-Yi
Wang, Jack P.
Lee, Rheun-Chuan
Lee, Wei-Ping
Li, Chung-Pin
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (03) : 637 - 642
[7] Gemcitabine in the treatment of metastatic pancreatic cancer
Hilbig, Andreas
Oettle, Helmut
EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (04) : 511 - 523
[8] Pancreatic cancer treatment and research: an international expert panel discussion
Tempero, M. A.
Berlin, J.
Ducreux, M.
Haller, D.
Harper, P.
Khayat, D.
Schmoll, H. -J.
Sobrero, A.
Van Cutsem, E.
ANNALS OF ONCOLOGY, 2011, 22 (07) : 1500 - 1506
[9] Antitumor activity and combined inhibitory effect of ceritinib with gemcitabine in pancreatic cancer
Jamshed, Muhammad Babar
Munir, Fahad
Shahid, Numan
Sadiq, Ussama
Muhammad, Syed Aun
Ghanem, Noor Bader
Zhong, Hong
Li, Xiaokun
Zhang, Qiyu
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2020, 318 (01): : G109 - G119
[10] Gemcitabine combined with docetaxel for the treatment of unresectable pancreatic carcinoma
Jacobs, AD
Otero, H
Picozzi, VJ
Aboulafia, DM
CANCER INVESTIGATION, 2004, 22 (04) : 505 - 514

← 1 2 3 4 5 →